Literature DB >> 25486589

A generic support vector machine model for preoperative glioma survival associations.

Kyrre E Emblem1, Marco C Pinho, Frank G Zöllner, Paulina Due-Tonnessen, John K Hald, Lothar R Schad, Torstein R Meling, Otto Rapalino, Atle Bjornerud.   

Abstract

PURPOSE: To develop a generic support vector machine (SVM) model by using magnetic resonance (MR) imaging-based blood volume distribution data for preoperative glioma survival associations and to prospectively evaluate the diagnostic effectiveness of this model in autonomous patient data.
MATERIALS AND METHODS: Institutional and regional medical ethics committees approved the study, and all patients signed a consent form. Two hundred thirty-five preoperative adult patients from two institutions with a subsequent histologically confirmed diagnosis of glioma after surgery were included retrospectively. An SVM learning technique was applied to MR imaging-based whole-tumor relative cerebral blood volume (rCBV) histograms. SVM models with the highest diagnostic accuracy for 6-month and 1-, 2-, and 3-year survival associations were trained on 101 patients from the first institution. With Cox survival analysis, the diagnostic effectiveness of the SVM models was tested on independent data from 134 patients at the second institution.
RESULTS: were adjusted for known survival predictors, including patient age, tumor size, neurologic status, and postsurgery treatment, and were compared with survival associations from an expert reader.
RESULTS: Compared with total qualitative assessment by an expert reader, the whole-tumor rCBV-based SVM model was the strongest parameter associated with 6-month and 1-, 2-, and 3-year survival in the independent patient data (area under the receiver operating characteristic curve, 0.794-0.851; hazard ratio, 5.4-21.2). DISCUSSION: Machine learning by means of SVM in combination with whole-tumor rCBV histogram analysis can be used to identify early patient survival in aggressive gliomas. The SVM model returned higher diagnostic accuracy values than an expert reader, and the model appears to be insensitive to patient, observer, and institutional variations. © RSNA, 2014 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25486589     DOI: 10.1148/radiol.14140770

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

Review 1.  Machine learning studies on major brain diseases: 5-year trends of 2014-2018.

Authors:  Koji Sakai; Kei Yamada
Journal:  Jpn J Radiol       Date:  2018-11-29       Impact factor: 2.374

2.  Predicting Inpatient Length of Stay After Brain Tumor Surgery: Developing Machine Learning Ensembles to Improve Predictive Performance.

Authors:  Whitney E Muhlestein; Dallin S Akagi; Jason M Davies; Lola B Chambless
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

3.  Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.

Authors:  Anna Latysheva; Kyrre Eeg Emblem; Petter Brandal; Einar Osland Vik-Mo; Jens Pahnke; Kjetil Røysland; John K Hald; Andrés Server
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

4.  Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?

Authors:  Torstein R Meling; Anna Latysheva; Michele Da Broi; Guro Jahr; Harald Holte; Klaus Beiske; Kyrre Eeg Emblem
Journal:  Neuroradiology       Date:  2018-05-27       Impact factor: 2.804

Review 5.  Precision Digital Oncology: Emerging Role of Radiomics-based Biomarkers and Artificial Intelligence for Advanced Imaging and Characterization of Brain Tumors.

Authors:  Reza Forghani
Journal:  Radiol Imaging Cancer       Date:  2020-07-31

Review 6.  Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

Authors:  Fabrício Guimarães Gonçalves; Sanjeev Chawla; Suyash Mohan
Journal:  J Magn Reson Imaging       Date:  2020-03-19       Impact factor: 4.813

7.  Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.

Authors:  Céline De Looze; Alan Beausang; Jane Cryan; Teresa Loftus; Patrick G Buckley; Michael Farrell; Seamus Looby; Richard Reilly; Francesca Brett; Hugh Kearney
Journal:  J Neurooncol       Date:  2018-05-16       Impact factor: 4.130

8.  Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Authors:  Lei Yang; Di Dong; Mengjie Fang; Yongbei Zhu; Yali Zang; Zhenyu Liu; Hongmei Zhang; Jianming Ying; Xinming Zhao; Jie Tian
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

9.  Using a Guided Machine Learning Ensemble Model to Predict Discharge Disposition following Meningioma Resection.

Authors:  Whitney E Muhlestein; Dallin S Akagi; Justiss A Kallos; Peter J Morone; Kyle D Weaver; Reid C Thompson; Lola B Chambless
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-08

10.  Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.

Authors:  Yanfen Cui; Huanhuan Liu; Jialiang Ren; Xiaosong Du; Lei Xin; Dandan Li; Xiaotang Yang; Dengbin Wang
Journal:  Eur Radiol       Date:  2020-01-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.